Filing metadata

Accession number
0000899243-20-030412
Form type
Form 4
Filer
Damora Therapeutics, Inc.
CIK
CIK 1800315
Filed
Nov 04, 2020
Reporting period
Nov 02, 2020
Description
Insider transaction

Explore SEC Filings Hub